The Unprecedented Growth of the Global Vaccine Administration Devices Market is Helping the Market to Thrive

Over 760 million children received vaccinations against vaccine-preventable diseases (VPDs) between 2000 and 2018, according to a report from the Global Alliance for Vaccines and Immunisation (GAVI). Chronic diseases are growing more prevalent, and more people are aware of the availability of free vaccines. In the near future, it is anticipated that the government organization's vaccine introduction would significantly accelerate the growth of the global market for vaccine administration devices.

Access full Report @ https://www.databridgemarketresearch.com/de/reports/global-vaccine-administration-devices-market

Data Bridge Market Research analyses a growth in the Global Vaccine Administration Devices Market in the forecast period 2022-2029. The expected CAGR of global vaccine administration devices market tends to be around 7.9% in the mentioned forecast period. The market was valued at USD 3.7 billion in 2021, and it would grow upto USD 6.80 billion by 2029. The global vaccine administration devices market is anticipated to increase as a result of expanding immunisation programmes, swift expansion of immunisation campaigns and initiatives, and rising disease rates across the globe.

Rising need and demand for needle-free technology is expected to drive the market's growth rate

The expansion of the market for vaccine administration devices is mostly due to the needleless delivery technology. These technologies offer the ability to lower the dose of vaccine antigens while also increasing the vaccine's immunogenicity. Rapid technical developments like electroporation and microneedling are projected to accelerate the market growth for vaccine administration devices. Microneedles are being used more frequently as a result of patients' growing demand for painless self-administration. Vaccines given intramuscularly take effect more slowly than those given dermally, which is what is driving the market's rise.

Report Scope and Market Segmentation

Segment Analysis:

The vaccine administration devices market is segmented on the basis of product, route of administration, brand, dosage, vaccine type, modality, usability, end user and distribution channel.

• On the basis of product, the vaccine administration devices market is segmented into syringes, auto injectors, jet injectors, micro needles, inhalation/pulmonary delivery, microinjection system, pen injector devices, biodegradable implants, electroporation-based needle free injection systems, buccal /sublingual vaccine delivery systems, auto-injector trainer devices and others devices. In 2021, syringes segment dominated the vaccine administration devices market with 31.50% market share because syringes are most normally used administration device and can be used in routine immunization.
• On the basis of route of administration, the vaccine administration devices market is segmented into intramuscular, subcutaneous, and intradermal. In 2021, intramuscular segment dominated the vaccine administration devices market with 60.70% market share because large number of healthcare professionals choose vaccine administration through this mode. 
• On the basis of type, the vaccine administration devices market is segmented into marketed vaccines and clinical-stage vaccines (electroporation).

In 2021, the marketed vaccines segment held the largest share of type segment in the vaccine administration devices market

Marketed vaccines segment dominated the vaccine administration devices market with 100.50% market share due to the availability of large number of devices in the market as per the need of patient and healthcare professionals.

• On the basis of brand, the vaccine administration devices market is segmented into BD accuspray nasal spray system, BD hypak for vaccines glass pre-fillable syringe system, BD uniject auto-disable pre-fillable injection system, Gx InnoSafe, Gx RTF clearject, plajex, and others. In 2021, BD accuspray nasal spray system segment dominated the vaccine administration devices market with 11.30% market share due to the availability of large number of the devices which can be used with several types of vaccine delivery.
• On the basis of dosage, the vaccine administration devices market is segmented into fixed and variable. In 2021, fixed segment dominated market with 65.70% market share because several vaccines are given with fixed dose to reduce the risk of toxicity as well as to reduce the variability of the vaccination.
• On the basis of vaccine type, the vaccine administration devices market is segmented into bivalent oral poliovaccine, BCG vaccine, tetanus-diphtheria vaccine, DTP-HEPB-HIB vaccine, influenza vaccine, pneumococcal conjugate vaccine, measles vaccine, and others. In 2021, bivalent oral polio vaccine segment dominated the vaccine administration devices market with 22.90% market share because of rising pediatric population globally and augmented government emphasis on the polio eradication worldwide.
• On the basis of modality, the vaccine administration devices market is segmented into automatic vaccine administration device and manual vaccine administration device.

In 2021, the automatic vaccine administration segment of modality segment is dominated the vaccine administration devices market

Automatic vaccine administration devices segment dominated the vaccine administration devices market with 55.20% market share due to growing advancement in the technology and increasing innovation in the field of vaccination devices. 

• On the basis of usability, the vaccine administration devices market is segmented into disposable and reusable. In 2021, disposable segment dominated the vaccine administration devices market with a 59.20% market share because the technologically advanced and novel syringes such as auto-disposable are gaining popularity worldwide.
• On the basis of end user, the vaccine administration devices market is segmented into hospitals, community centers, homecare setting, research and academic institutes, ambulatory surgical center, and others. In 2021, hospitals segment dominated the vaccine administration devices market with 35.10% market share because affected individual may seek special help or guidance from the hospitals or patient may approach hospitals for the vaccination or immunization.
• On the basis of distribution channel, the vaccine administration devices market is segmented into direct tenders, retail sales and others. In 2021, direct tenders segment dominated the vaccine administration devices market with 58.20% market share because the immunization can be done on huge scale by government authorities.

Major Players

Data Bridge Market Research recognizes the following companies as the major market players: BD (U.S.), INOVIO Pharmaceuticals (U.S.), Vaxxas (U.S.), Gerresheimer AG (Germany), Corium Inc. (U.S.), Enesi (U.S.), Micropoint Technologies (Singapore), SCHOTT AG (Germany), 3M (U.S.), Mystic Pharmaceuticals (U.S.), NanoPass Rev (U.S.), Terumo Europe NV (Belgium), D'Antonio Consultants International, Inc. (U.S.), West Pharmaceutical Services, Inc. (U.S.)., Mylan N.V. (U.S.), Medical International Technologies Inc. (Canada),  Antares Pharma (U.S.).

Market Development

• In 2020, Inovio Pharmaceuticals, Inc. and Beijing Advaccine Biotechnology Co. worked together to develop INO-4800, an Inovio vaccine that was used in China to protect against the 2019-nCoV coronavirus. This partnership helped the business establish a better platform for developing vaccines and vaccine delivery systems.
• In 2020, a manufacturing agreement for the creation of a genetic vaccination to combat COVID-19 was signed by scientists from Massachusetts Eye and Ear and Massachusetts General Hospital in the U.S.. By the second half of 2020, this vaccine, known as AAVCOVID, is expected to be available.
• In 2020, In order to scale up the production of INOVIO's investigational COVID-19 DNA vaccine INO-4800, Richter-Helm BioLogics GmbH & Co. KG, a German contract manufacturer, and INOVIO entered into a partnership agreement. Deliveries of the INOVIO-designed vaccine will be made to CELLCETRA.

Regional Analysis

Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (M.E.A.) as a part of Middle East and Africa (M.E.A.), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in the vaccine administration devices market during the forecast period 2022 to 2029

As a result of expanding immunisation rates and increasing spending in R&D for novel vaccines, North America currently holds a monopoly on the market for vaccine administration devices. A significant portion of the market expansion for vaccine administration devices in this region has also been attributed to the region's advanced healthcare infrastructure and rising public and professional awareness.   

Asia-Pacific is estimated to be the fastest growing region in the vaccine administration devices market in the forecast period 2022 to 2029

Given its fast developing infrastructure, Asia-Pacific is predicted to increase between 2022 and 2029. Additionally, it is projected that rising vaccination expenditures and exhibiting good ownership and management of immunisation programmes will accelerate market expansion in this region. 

For more detailed information about the vaccine administration devices market report, click here – https://www.databridgemarketresearch.com/de/reports/global-vaccine-administration-devices-market